Drucker tells me that, anecdotally, he gets asked about this potential use a lot
2026 Rules VA and TRICARE GLP-1 coverage in 2026: who qualifies for Wegovy or Zepbound, CHAMPVA rules, whether active duty can take GLP-1s, and what to do if denied
Patients with a history of chronic pancreatitis, pancreatic cancer, or other significant pancreatic disorders may not be suitable candidates for this therapy
In our inreach effort, which was concurrent to the outreach effort, PCPs were encouraged to optimize drug regimens with a SGLT2 inhibitor or GLP-1 RA for all appropriate patients during regularly scheduled primary care appointments
Visible weight-loss results often become more noticeable between 8 and 12 weeks, though timelines vary from person to person